U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214545) titled 'External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms' on Sept. 11.

Brief Summary: The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are:

* Does eTNS reduce ADHD symptoms?

* Does eTNS improve core and associated features of ASD?

Participation spans 8-12 weeks and includes:

* 4-5 in-person visits

* 4 brief virtual check-ins

* Nightly use of the eTNS device with a sma...